Menu
Log in



Your Resource for Neurotherapeutics Discovery and Development


Upcoming events

    • March 10, 2025
    • March 11, 2025
    • Hyatt Regency Bethesda, Bethesda MD

    Training in Neurotherapeutic Clinical Trials: Development and Implementation Course

    APPLICATION DEADLINE EXTENDED: NOVEMBER 19, 2024

    APPLY TODAY

    DOWNLOAD THE BROCHURE

    About the Course

    • Format: In Person 
    • Application: Free 
    • Tuition: $450 for Accepted Applicants 
    • Requirements: Completed Application 
    • Credentials Provided: Certificate of Completion 
    • Included: Course materials, Discounted Registration for ASENT Annual Meeting, Discounted fee to Submit Abstract to ASENT. 
    • Not Included: Travel and Hotel is not included for all participants

    ASENT is pleased to offer a 2-day course March 10-11, 2025 at the Hyatt Regency Bethesda, in Bethesda, MD to introduce researchers and clinicians to the principles of neurotherapeutic clinical trial development and implementation. The course will be especially relevant if you are interested in conducting neurotherapeutic clinical trials.

    The course covers the principles of clinical trials from pre-clinical programs to Phase III design and implementation, including necessary regulatory conversations and IND enabling studies, IRB oversight and adverse event tracking and reporting. The course considers clinical trials in the neurotherapeutic space for both drugs and devices. The course will also address the unique challenges inherent in developing treatments for nervous system disorders. 

    The course will feature a mix of:

    • Didactic sessions that go in depth into a wide range of topics

    • Interactive workshops where participants will work in teams on projects such as drafting protocols and addressing adverse events 

    • Panel discussions with lively Q&A 

    • Discounted access to the ASENT Annual Meeting

    APPLY TODAY

    DOWNLOAD THE BROCHURE


    Participants who attend the course will have ongoing access to senior faculty in attendance in a mentoring capacity. We anticipate that most applicants will have some familiarity with clinical research however, any clinical investigator who would benefit from the course is invited to apply. Those in industry and in private practice are also welcome to apply. The course will be offered annually and participants have discounted access to the ASENT Annual Meeting.

    You will be asked to provide:

    • Name
    • Contact Information
    • CV
    • A one page letter of interest

    We are excited to have the opportunity to offer this course, which we believe will help to advance the availability of new drugs for patients with neurological conditions. If your work would benefit from an understanding of neurologic clinical trials you are encouraged to apply.

    APPLY TODAY

    DOWNLOAD THE BROCHURE


    • March 10, 2025
    • 7:30 AM
    • March 11, 2025
    • 7:30 PM
    • Hyatt Regency Bethesda
    Register

    About This Training Program

    ASENT is pleased to offer a 2-day course March 10-11, 2025 at the Hyatt Regency Bethesda, in Bethesda, MD to introduce clinicians interested in clinical research to the principles of neurotherapeutic clinical trial development and implementation. The course will be especially relevant if you are a neurologist with clinical experience interested in conducting neurotherapeutic clinical trials.

    The course covers the principles of clinical trials from pre-clinical programs to Phase III design and implementation, including necessary regulatory conversations and IND enabling studies, IRB oversight and adverse event tracking and reporting. The course considers clinical trials in the neurotherapeutic space for both drugs and devices. The faculty will also address the unique challenges inherent in developing treatments for nervous system disorders. 


    • March 12, 2025
    • 8:00 AM
    • March 14, 2025
    • 1:00 PM
    • Hyatt Regency Bethesda, Bethesda, MD
    Register

    ABOUT ASENT 2025 Annual Meeting

    The ASENT 2025 Annual Meeting, which will take place March 12 - 14, 2025 at the Hyatt Regency Bethesda in Bethesda, MD, is the premier neuroscience and neurotherapeutics conference where senior leaders from leading payers, providers, employers, investors, fast-growing startups, pharma, policymakers, funders and innovation centers gather with one central focus, improving the process of bringing neurotherapeutics to market.

    The plenary sessions, panel discussions, outstanding pipeline presentations and poster sessions focus on the latest science in neurotherapeutics. The conference content will focus on the latest science in neurotherapeutics including innovations across disease states, novel delivery systems, gene therapy and biomarkers, and of course the latest drug therapies and devices. The event features plenary sessions, panel discussions, satellite luncheons, networking meetings, pipeline presentations and poster sessions.

    WHO ATTENDS

    Physician-Scientists | Neurologists | Neuroscientists | Trainees | Drug and Device Companies | CROs | Fellows | Post-docs | Founders | Funders | Industry Leaders | Nonprofit Organizations and Advocacy Groups | Journal Editors | Representatives from NIH, NIA, NIDA, NINDS and FDA


Powered by Wild Apricot Membership Software